Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel drug candidates for patients with immuno-inflammatory diseases lacking satisfactory treatment options. The company boasts a multi-stage portfolio driven by a strong R&D focus on protein kinase regulation.
